Pfizer's had a weird couple of weeks. The CFO announced he's leaving in August for a job in consumer goods, and the stock dropped on the news. I get that a change in leadership can make people nervous, but they already named an interim replacement and said the numbers haven't changed. If the guidance is still the same, why the panic?
Then they declared another dividend, which is something at least, and some analysts still see a lot of upside. But there was also a lung cancer dr-g trial that missed its main goal, so it's not like there's nothing to worry about. I keep going back and forth on this one, not sure if this dip is worth buying into or if I should just take what I can get and move on.